Price
No data yet.
Social Signal Score
Revenue
$365.39M+38.41%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Christopher J. Bilotto
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Employees
- 600
- Beta
- 2.31
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- -0.22
Financials
Revenue
$365.39M+38.4%Net Income
$-37.42M-234.1%EBITDA
$63.47M-56.7%Free Cash Flow
$-35.53M-129.4%EPS (diluted)
$-0.16-233.3%Shares Outstanding (diluted)
240.75M+1.4%Operating Expenses
$19.33MCash & Debt
$116.79MReturn of Capital
$2.47MRevenue by Segment (annual)
$1.54BDividend per Share
$0.01Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.54B | $-285.89M | $-1.19 |
| 2024 | $1.50B | $-370.25M | $-1.55 |
| 2023 | $1.41B | $-293.57M | $-1.23 |
| 2022 | $1.28B | $-15.77M | $-0.07 |
| 2021 | $1.38B | $174.51M | $0.73 |
| 2020 | $1.63B | $-139.45M | $-0.59 |
| 2019 | $1.04B | $-88.23M | $-0.37 |
| 2018 | $1.12B | $286.87M | $1.21 |
| 2017 | $1.07B | $147.61M | $0.62 |
| 2016 | $1.06B | $141.29M | $0.60 |
| 2015 | $998.77M | $123.97M | $0.54 |
| 2014 | $844.89M | $158.64M | $0.81 |
| 2013 | $761.44M | $151.16M | $0.98 |
| 2012 | $634.80M | $131.82M | $0.78 |
Valuation
DHChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
125Social Signal Score
Mentions (1)
- Newsseekingalpha.com·6h ago·Positive
Diversified Healthcare Trust: A Cautious Buy Diversified Healthcare Trust is rated 'Buy' as fundamentals and balance sheet have improved despite recent share price gains. Q2 2026 saw SHOP NOI up 37.2% YoY and margin expansion, with normalized FFO surging 109.4% to $0.16/share. DHC's deleveraging is notable: net debt to adjusted EBITDAre fell to 7.1x, with no major maturities until 2028 and $270M in liquidity.
View source ↗
Earnings
Mon, Nov 2(in 2 months)
Consensus estimate $-0.15 per share
Typical surprise +118.6% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$-0.16 vs $-0.15miss
- Mon, May 4$-0.18 vs $-0.16miss
- Mon, Feb 23$0.09 vs $-0.17beat
- Mon, Nov 3$0.04 vs $-0.21beat
- Mon, Aug 4$0.08 vs $-0.22beat
- Mon, May 5$0.06 vs $-0.25beat
Estimates and results for DHC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by DHC officers and directors.
- Bought
- $46.8m
- Sold
- $174k
12 trades
2 trades
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
86 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.